4-(2-phenyl-5-7-bis(trifluoromethyl)pyrazolo(1-5-a)pyrimidin-3-yl)phenol has been researched along with Diabetic-Foot* in 1 studies
1 other study(ies) available for 4-(2-phenyl-5-7-bis(trifluoromethyl)pyrazolo(1-5-a)pyrimidin-3-yl)phenol and Diabetic-Foot
Article | Year |
---|---|
Selective blockade of estrogen receptor beta improves wound healing in diabetes.
Topics: Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetic Foot; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Estrogen Receptor beta; Humans; Mice, Knockout; Piperidines; Pyrazoles; Pyrimidines; Wound Healing | 2014 |